Discover how understanding your viral load and CD4 count puts you in control of HIV treatment and transforms confusing ...

Is the cost of research aimed at curing HIV worth it, when HIV can be effectively managed and prevented by existing drugs?

This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.

The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...

So despite the success of HIV drugs and PrEP, precarious health-care systems and high drug costs mean we can't rely on them to bring an end to the ongoing global HIV pandemic. Tha ...

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

Click through and find out how scientists are searching for an HIV cure, and what's been achieved over the last four decades.

Gilead and MSD showcase once-weekly oral HIV regimen at CROI congress, as ViiV presents new data on injectable Cabenuva in patients with low adherence to daily oral therapy.

In a phase 2 trial, an antiretroviral combination developed by Gilead Sciences and MSD suppressed HIV with a single weekly oral dose, raising the hope of a new treatment option for patients.

The field of HIV treatment has witnessed a significant transformation since the mid-1990s with the introduction of combination antiretroviral therapy ...

Researchers revealed a 3.6 Å cryo-EM structure showing how HIV-1 Vif hijacks the host’s CUL5 E3 ligase to degrade APOBEC3H, a viral defense protein. The findings shed light on HIV’s immune ...